FDA Approves SalivaDirect via Emergency Use Authorization


Last update: 08/17/2020

The less invasive, lower cost SalivaDirect COVID-19 diagnostic test was issued an emergency use authorization by the FDA on 8/15/2020. This new test collects saliva in any sterile container, and does not require a separate nucleic acid extraction step. This saves time and money, and offers a real hope for expanded testing throughout the country. Here’s the link to the FDA notice;  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-yale-school-public-health